396 related articles for article (PubMed ID: 23734688)
1. Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity.
Walton-Diaz A; Khan S; Bourboulia D; Trepel JB; Neckers L; Mollapour M
Future Med Chem; 2013 Jun; 5(9):1059-71. PubMed ID: 23734688
[TBL] [Abstract][Full Text] [Related]
2. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
Li J; Richter K; Reinstein J; Buchner J
Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
[TBL] [Abstract][Full Text] [Related]
3. Post-translational modifications of Hsp90 and their contributions to chaperone regulation.
Mollapour M; Neckers L
Biochim Biophys Acta; 2012 Mar; 1823(3):648-55. PubMed ID: 21856339
[TBL] [Abstract][Full Text] [Related]
4. A primate specific extra domain in the molecular chaperone Hsp90.
Tripathi V; Obermann WM
PLoS One; 2013; 8(8):e71856. PubMed ID: 23951259
[TBL] [Abstract][Full Text] [Related]
5. Post-translational modifications of Hsp90 and translating the chaperone code.
Backe SJ; Sager RA; Woodford MR; Makedon AM; Mollapour M
J Biol Chem; 2020 Aug; 295(32):11099-11117. PubMed ID: 32527727
[TBL] [Abstract][Full Text] [Related]
6. Detecting Posttranslational Modifications of Hsp90.
Sager RA; Woodford MR; Neckers L; Mollapour M
Methods Mol Biol; 2018; 1709():209-219. PubMed ID: 29177662
[TBL] [Abstract][Full Text] [Related]
7. p23 and Aha1.
Rehn AB; Buchner J
Subcell Biochem; 2015; 78():113-31. PubMed ID: 25487019
[TBL] [Abstract][Full Text] [Related]
8. The role of p23, Hop, immunophilins, and other co-chaperones in regulating Hsp90 function.
Cox MB; Johnson JL
Methods Mol Biol; 2011; 787():45-66. PubMed ID: 21898226
[TBL] [Abstract][Full Text] [Related]
9. Detecting Posttranslational Modifications of Hsp90 Isoforms.
Sager RA; Backe SJ; Neckers L; Woodford MR; Mollapour M
Methods Mol Biol; 2023; 2693():125-139. PubMed ID: 37540432
[TBL] [Abstract][Full Text] [Related]
10. The regulatory mechanism of a client kinase controlling its own release from Hsp90 chaperone machinery through phosphorylation.
Lu XA; Wang X; Zhuo W; Jia L; Jiang Y; Fu Y; Luo Y
Biochem J; 2014 Jan; 457(1):171-83. PubMed ID: 24117238
[TBL] [Abstract][Full Text] [Related]
11. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
Li J; Soroka J; Buchner J
Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer.
Kou X; Jiang X; Liu H; Wang X; Sun F; Han J; Fan J; Feng G; Lin Z; Jiang L; Yang Y
Cancer Sci; 2018 Oct; 109(10):3272-3284. PubMed ID: 30039622
[TBL] [Abstract][Full Text] [Related]
13. Stability of the human Hsp90-p50Cdc37 chaperone complex against nucleotides and Hsp90 inhibitors, and the influence of phosphorylation by casein kinase 2.
Olesen SH; Ingles DJ; Zhu JY; Martin MP; Betzi S; Georg GI; Tash JS; Schönbrunn E
Molecules; 2015 Jan; 20(1):1643-60. PubMed ID: 25608045
[TBL] [Abstract][Full Text] [Related]
14. Structure, function and regulation of the hsp90 machinery.
Li J; Buchner J
Biomed J; 2013; 36(3):106-17. PubMed ID: 23806880
[TBL] [Abstract][Full Text] [Related]
15. The 'active life' of Hsp90 complexes.
Prodromou C
Biochim Biophys Acta; 2012 Mar; 1823(3):614-23. PubMed ID: 21840346
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70.
Carrello A; Allan RK; Morgan SL; Owen BA; Mok D; Ward BK; Minchin RF; Toft DO; Ratajczak T
Cell Stress Chaperones; 2004; 9(2):167-81. PubMed ID: 15497503
[TBL] [Abstract][Full Text] [Related]
17. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
Smith JR; Workman P
Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of chaperoning process by taxifolin: molecular dynamics simulation study.
Verma S; Singh A; Mishra A
J Mol Graph Model; 2012 Jul; 37():27-38. PubMed ID: 22609743
[TBL] [Abstract][Full Text] [Related]
19. Conformational dynamics of the molecular chaperone Hsp90 in complexes with a co-chaperone and anticancer drugs.
Phillips JJ; Yao ZP; Zhang W; McLaughlin S; Laue ED; Robinson CV; Jackson SE
J Mol Biol; 2007 Oct; 372(5):1189-203. PubMed ID: 17764690
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones.
Prodromou C; Siligardi G; O'Brien R; Woolfson DN; Regan L; Panaretou B; Ladbury JE; Piper PW; Pearl LH
EMBO J; 1999 Feb; 18(3):754-62. PubMed ID: 9927435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
